Answer
Ezetimibe acts at the small intestine's brush border, targeting the sterol transporter Niemann-Pick C1-Like 1 (NPC1L1) to selectively inhibit absorption of cholesterol and related plant sterols, thereby reducing delivery of intestinal cholesterol to the liver.
Sources for this answer
- Ezetimibe 10 mg TabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked